Jun 18, 2026 08:31AM
Jun 18, 2026 08:30AM
Jun 4, 2026 08:31AM
Jun 4, 2026 08:30AM
Jun 2, 2026 08:31AM
Jun 2, 2026 08:30AM
May 7, 2026 08:30AM Quoin Pharmaceuticals Provides Corporate Update and Reports First Quarter 2026 Financial Results
Apr 28, 2026 12:02PM
Apr 28, 2026 08:32AM
Apr 28, 2026 08:30AM
Mar 26, 2026 08:30AM
Mar 25, 2026 08:31AM
Mar 25, 2026 08:30AM
Mar 11, 2026 08:30AM Quoin Pharmaceuticals receives FDA fast track designation for QRX003
Mar 11, 2026 08:30AM
Jan 27, 2026 08:31AM
Jan 27, 2026 08:30AM
Jan 20, 2026 08:30AM
Nov 11, 2025 08:31AM
Nov 11, 2025 08:30AM
Nov 6, 2025 08:30AM Quoin Pharmaceuticals Announces Corporate Update and Third Quarter 2025 Financial Results
Oct 21, 2025 08:30AM
Oct 21, 2025 08:30AM
Oct 10, 2025 09:25AM
Oct 10, 2025 09:24AM
Aug 7, 2025 08:30AM
Jun 26, 2025 08:30AM
Jun 24, 2025 08:34AM Quoin Pharmaceuticals Ltd (QNRX) Granted FDA Rare Pediatric Disease Designation for QRX003
Jun 24, 2025 08:30AM
May 22, 2025 07:31AM
May 22, 2025 07:30AM
May 13, 2025 08:00AM
Apr 10, 2025 07:30AM
Mar 25, 2025 07:31AM
Mar 25, 2025 07:30AM Quoin Pharmaceuticals Files U.S. Patent Application for Novel Topical Formulations to Treat Netherton Syndrome and Other Skin Diseases
Mar 13, 2025 07:30AM
Mar 4, 2025 07:30AM
Mar 4, 2025 07:30AM
Feb 4, 2025 07:30AM
Jan 23, 2025 08:30AM
Jan 23, 2025 05:30AM
Jan 14, 2025 08:34AM Quoin Pharmaceuticals (QNRX) Announces Further Positive Clinical Data from Ongoing Pediatric Netherton Syndrome Study
Jan 14, 2025 08:30AM
Jan 7, 2025 02:29PM
Jan 6, 2025 08:33AM
Jan 6, 2025 08:30AM
Dec 19, 2024 08:00AM
Nov 7, 2024 08:00AM
Nov 5, 2024 08:02AM Quoin Pharmaceuticals (QNRX) Initiates Clinical Testing of Lead Product in Pediatric Netherton Syndrome Patient
Nov 5, 2024 08:00AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All